Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
Now Live:
Breaking Research From XVII International AIDS Conference >>
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy
Antiretroviral Therapy
Acute Infection
Antiretrovirals
Assays (Diagnostic & Monitoring)
Guidelines
Initial Therapy
Pediatrics
Resistance
Salvage Therapy
Second/Third-Line Treatment
Structured Treatment Interruptions
Women & Pregnancy
More ...
Complications of HIV/HAART
Complications of HIV/HAART
Overview
Cardiovascular
Lipoatrophy
Gastrointestinal
Hepatitis
HPV & Cervical/Anal Cancer
Liver Complications
Malignancies
Mental Health
Metabolic
Neurocognitive
Renal Complications
Women-Specific
More ...
Research & Development
Research & Development
Overview
Antiretrovirals in Development
Conference Reports
HIV Genetics
HIV Immunology
More ...
Clinical Trials
Clinical Trials
Overview & News
U.S. Databases
U.S. Nationwide Studies
U.S. State-by-State Trial Listings
Databases Outside U.S.
Specific Trials Outside U.S.
More ...
Quality of Life & Patient Care
Quality of Life & Patient Care
Complementary Medicine
Mental Health
Primary Care
Pre-Exposure Prophylaxis
Overview
|
News & Research
Overview
CDC Trials of Daily Oral Tenofovir for Preventing HIV Infection
(December 7, 2005)
To read PDF,
click here
From
U.S. Centers for Disease Control and Prevention
CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention
(June 2005)
Available only in PDF.
From
U.S. Centers for Disease Control and Prevention
News & Research
New Frontiers in HIV Prevention: Male Circumcision and Pre-Exposure Prophylaxis in the United States -- An Interview at CROI 2007 With Patrick Sullivan, Ph.D., and Lynn Paxton, M.D., M.P.H.
(February 27, 2007)
In
Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections
, from
The Body PRO
HIV Clinical Trial Aiming to Increase Participation of Black MSM
(January 11, 2007)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Antiretroviral Drugs as Prevention Tools: PEP, PrEP and Prevention for Positives
(September 27, 2006)
In
46th Interscience Conference on Antimicrobial Agents and Chemotherapy
PrEP Studies Show Possible Effectiveness; Scientists Say Further Tests Must Be Completed for Confirmation
(August 14, 2006)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Some MSM Already Using Tenofovir as Method of HIV Prevention, Outside of Clinical Trials
(December 19, 2005)
Physicians and HIV prevention experts say tenofovir has been sold in gay dance clubs around the country and prescribed by some physicians for prevention.
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Family Health International Will Seek Support From Gates Foundation for Tenofovir Trials to Prevent HIV
(August 5, 2005)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Antiretroviral Drug Researchers, AIDS Advocates Fail to Reach Consensus Over Viread Trials in Developing Countries
(May 24, 2005)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Fact Sheet on "Project T": A Safety Study of Daily Oral Tenofovir to Prevent HIV Infection in HIV-Negative Men Who Have Sex With Men (PDF)
(December 2004)
Study sites are in San Francisco and Atlanta.
From San Francisco Department of Public Health
Cambodian Sex Workers Refuse to Participate in Tenofovir HIV Prevention Trial
(March 30, 2004)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
"It's OK, I'm on the AIDS Pill"
(February 26, 2004)
Tenofovir (Viread) is being tested as a "morning-after" pill to prevent HIV infection. But if it's found to work, could it cause more problems than it solves?.
In
Wired News
Prevention: New Approach Will Test Tenofovir for Persons at High Risk
(November 22, 2002)
A brief analysis of the study's significance for women.
In
AIDS Treatment News
, from
AIDS Treatment News
$6.5M Set Aside to Study Tenofovir as HIV-Prevention Pill
(November 5, 2002)
In
CDC HIV/Hepatitis/STD/TB Prevention News Update
, from
U.S. Centers for Disease Control and Prevention